Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-06-07

FDA Approved: RIZATRIPTAN BENZOATE — Supplemental Application (Macleods Pharmaceuticals Limited)

View source ↗

Summary

The FDA approved a supplemental application for rizatriptan benzoate submitted by Macleods Pharmaceuticals Limited. It concerns a supplemental approval for this…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Rizatriptan Benzoate (rizatriptan benzoate)

Snippet

SUPPL AP for RIZATRIPTAN BENZOATE (RIZATRIPTAN BENZOATE)